The process of formulating a cancer drug typically involves several steps:
Preformulation Studies: Initial studies to understand the physicochemical properties of the drug, including solubility, stability, and compatibility with other ingredients. Formulation Development: Designing the dosage form and selecting suitable excipients to enhance the drug's performance. In Vitro Testing: Laboratory tests to evaluate the formulation's effectiveness and safety. In Vivo Testing: Animal studies to further assess the drug's pharmacokinetics and pharmacodynamics. Clinical Trials: Human trials to confirm the safety and efficacy of the formulation.
